| Toxicity of boric acid, borax and other boron containing compounds: A review | Regulatory toxicology and pharmacology | 176 days | save |  |  |  |  |
| Expanding the toxicologist's statistical toolbox: Using effect size estimation and dose-response modelling for holistic assessments instead of generic testing | Regulatory toxicology and pharmacology | 178 days | save | | | | |
| Compounded conservatism in European re-entry worker risk assessment of pesticides | Regulatory toxicology and pharmacology | 178 days | save | | | | |
| Increasing confidence in waiving dermal toxicity studies: A comparison of oral and dermal acute data with alternative approaches for agrochemicals and products | Regulatory toxicology and pharmacology | 183 days | save | | | | |
| A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling | Regulatory toxicology and pharmacology | 184 days | save | | | | |
| Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential | Regulatory toxicology and pharmacology | 184 days | save | | | | |
| Risk assessment of predicted serum concentrations of bisphenol A in children and adults following treatment with dental composite restoratives, dental sealants, or orthodontic adhesives using physiologically based pharmacokinetic modeling | Regulatory toxicology and pharmacology | 184 days | save | | | | |
| Estimation of toluene exposure in air from BMA (S-benzylmercapturic acid) urinary measures using a reverse dosimetry approach based on physiologically pharmacokinetic modeling | Regulatory toxicology and pharmacology | 184 days | save | | | | |
| Comparative In vitro metabolism of purified mogrosides derived from monk fruit extracts | Regulatory toxicology and pharmacology | 184 days | save | | | | |
| Evaluation of the carcinogenicity of dichloromethane in rats, mice, hamsters and humans | Regulatory toxicology and pharmacology | 194 days | save | | | | |
| The use of emerging safety biomarkers in nonclinical and clinical safety assessment – The current and future state: An IQ DruSafe industry survey | Regulatory toxicology and pharmacology | 194 days | save | | | | |
| Testing the validity of a proposed dermal cancer slope factor for Benzo[a]pyrene | Regulatory toxicology and pharmacology | 199 days | save | | | | |
| Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity | Regulatory toxicology and pharmacology | 205 days | save | | | | |
| A 13-week subchronic toxicity study of a Dioscorea Rhizome water extract in rats | Regulatory toxicology and pharmacology | 205 days | save | | | | |
| Non-dioxin-like polychlorinated biphenyl neurotoxic equivalents found in environmental and human samples | Regulatory toxicology and pharmacology | 210 days | save | | | | |
| Reproductive and developmental toxicity screening study of an acetone extract of rosemary | Regulatory toxicology and pharmacology | 212 days | save | | | | |
| Evidence-based regulations for bioinformatic prediction of allergen cross-reactivity are needed | Regulatory toxicology and pharmacology | 218 days | save | | | | |
| Antimony release from polyester textiles by artificial sweat solutions: A call for a standardized procedure | Regulatory toxicology and pharmacology | 218 days | save | | | | |
| Pharmacokinetics and efficacy of atropine sulfate/obidoxime chloride co-formulation against VX in a guinea pig model | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| A review to support the derivation of a worst-case dermal penetration value for nanoparticles | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| Subchronic toxicity study in rats evaluating herbicide-tolerant soybean DAS-68416-4 | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| Simple methodology for ensuring the precision of measuring radioactivity at low concentrations in very small tissues using quantitative whole-body autoradiography | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| Evaluating chemical similarity as a measure to identify potential substances of very high concern | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studies | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| Assessment of the potential allergenicity and toxicity of Pichia proteins in a novel leghemoglobin preparation | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| A call for action on the development and implementation of new methodologies for safety assessment of chemical-based products in the EU – A short communication | Regulatory toxicology and pharmacology | 231 days | save | | | | |
| Safety assessment of ethanolic root extract of Zaleya decandra (EEZD) in Wistar rats | Regulatory toxicology and pharmacology | 235 days | save | | | | |
| The activity of methacrylate esters in skin sensitisation test methods II. A review of complementary and additional analyses | Regulatory toxicology and pharmacology | 252 days | save | | | | |
| Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies | Regulatory toxicology and pharmacology | 255 days | save | | | | |
| Facilitation of risk assessment with evidence-based methods – A framework for use of systematic mapping and systematic reviews in determining hazard, developing toxicity values, and characterizing uncertainty | Regulatory toxicology and pharmacology | 261 days | save | | | | |
| Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophen | Regulatory toxicology and pharmacology | 261 days | save | | | | |
| Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials | Regulatory toxicology and pharmacology | 267 days | save | | | | |
| A review of clinical pharmacology deficiencies of European centralised drug marketing authorisation applications | Regulatory toxicology and pharmacology | 274 days | save | | | | |
| Assessment of veterinary drug residues in food: Considerations when dealing with sub-optimal data | Regulatory toxicology and pharmacology | 282 days | save | | | | |
| A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals | Regulatory toxicology and pharmacology | 286 days | save | | | | |
| Toxicological risk assessment of bisphenol a released from dialyzers under simulated-use and exaggerated extraction conditions | Regulatory toxicology and pharmacology | 286 days | save | | | | |
| Safety of medicinal comfrey cream preparations (Symphytum officinale s.l.): The pyrrolizidine alkaloid lycopsamine is poorly absorbed through human skin | Regulatory toxicology and pharmacology | 290 days | save | | | | |
| Acute and sub-chronic toxicity studies of Benincasa hispida (Thunb.) cogniaux fruit extract in rodents | Regulatory toxicology and pharmacology | 300 days | save | | | | |
| Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: A case study with resorcinol | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Iraqi regulatory authority current system and experience with biosimilars | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019 | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| A toxicological evaluation of monomethylsilanetriol (MMST) stabilized in acacia gum, a novel silicon preparation | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Use of mechanistic information to derive chemical-specific adjustment factors – Refinement of risk assessment | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| DP-2Ø2216-6 maize does not adversely affect rats in a 90-day feeding study | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Safety testing of adult novelties using in vitro methods | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| A 26-week toxicological study of Xuezhikang (XZK), red yeast rice extract, in Beagle dogs with a 4-week recovery period | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Four-week repeated dose oral toxicity study of KDS2010, a novel selective monoamine oxidase B inhibitor, in Sprague Dawley rats | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Effects of an ethanolic extract and fractions from Piper glabratum (Piperaceae) leaves on pain and inflammation | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Development of peptide therapeutics: A nonclinical safety assessment perspective | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| Reflections on the OECD guidelines for in vitro skin absorption studies | Regulatory toxicology and pharmacology | 313 days | save | | | | |
| | 
report | next » |
| |
